Public procurement notice: Contract Notice
Published: 2025-09-24
Buyer: SYKEHUSINNKJØP HF
Country: NO
Region: NO073
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 890000000 NOK
Submission deadline: 2025-10-13
Award criteria: price

Technical requirements: The procurement concerns medicines for the four health companies: Health South-East RHFHelse West RHFHealance Mid-Norway RHFHealth North RHFAnskaffelsen applies to active substances without biotiles corresponding competition for treatment against diseases of the skin, joints and intestine. The total contract extent is estimated in net procurement value to approx. NOK 890 million per annum based on historical consumption. See Annex 3 Requirement Specifications and The Competition Provisions for detailed information.
The contracting authority for this competition is Sykehusinnkjøp HF on behalf of the four regional health authorities in Norway, Helse Sør-Øst, Helse Vest, Helse Midt-Norway and Helse Nord. The competition is for active substances without a bio-persistent competition for treatment of decommitting diseases in the skin, joints and intestines. The total contract extent is estimated in net procurement value to approx. NOK 890 million per annum based on historical consumption. The contracts shall cover the need as it is at all times. Historical consumption is only a guideline for consumption in the coming contract period.
Tenderers shall have a valid wholesaler licence or production licence in the EU/EEA.
Each tenderer must document that it holds a valid wholesaler licence or manufacturer licence for its own preparations in the EU/EEA area at the time of the tender offer. If the tenderer does not have a wholesaler or production licence itself, but e.g. acts on behalf of the group/parent company or has an agency, the commitment statement and ESPD form from the holder of the wholesaler/production permission for the offered products shall be enclosed.

Eligibility requirements: Tenderers shall have a valid wholesaler licence or production licence in the EU/EEA.
Each tenderer must document that it holds a valid wholesaler licence or manufacturer licence for its own preparations in the EU/EEA area at the time of the tender offer. If the tenderer does not have a wholesaler or production licence itself, but e.g. acts on behalf of the group/parent company or has an agency, the commitment statement and ESPD form from the holder of the wholesaler/production permission for the offered products shall be enclosed.
By the waiting period expiry
The contracting authority for this competition is Sykehusinnkjøp HF on behalf of the four regional health authorities in Norway, Helse Sør-Øst, Helse Vest, Helse Midt-Norway and Helse Nord. The competition is for active substances without a bio-persistent competition for treatment of decommitting diseases in the skin, joints and intestines. The total contract extent is estimated in net procurement value to approx. NOK 890 million per annum based on historical consumption. The contracts shall cover the need as it is at all times. Historical consumption is only a guideline for consumption in the coming contract period.